Role of NADPH oxidase in interleukin-4-induced monocyte chemoattractant protein-1 expression in vascular endothelium

Inflammation Research

Volumn 59, Issue 9, 2010, Pages 755-765

  Lee, Yong Woo ^a   Lee, Won Hee ^a   Kim, Paul H ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

IL 4; MCP 1; NADPH oxidase; Reactive oxygen species; Vascular endothelium

Indexed keywords

EPIGALLOCATECHIN GALLATE; INTERLEUKIN 4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; C57BL 6 MOUSE; CELL MIGRATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY CHAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIOXIDANTS; AORTA; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; UP-REGULATION;

EID: 77955655797     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0187-3     Document Type: Article

References (63)

1. YW Lee B Hennig M Toborek 2003 Redox-regulated mechanisms of interleukin-4-induced MCP-1 expression in human vascular endothelial cells Am J Physiol Heart Circ Physiol 284 H185 H192 1:CAS:528:DC%2BD3sXmvF2jtg%3D%3D 12388243
2. BJ Rollins JS Pober 1991 Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells Am J Pathol 138 1315 1319 1:CAS:528:DyaK3MXlsFKktLk%3D 2053591
3. A Bouloumie T Marumo M Lafontan R Busse 1999 Leptin induces oxidative stress in human endothelial cells FASEB J 13 1231 1238 1:CAS:528: DyaK1MXktlOrurw%3D 10385613
4. RM Strieter R Wiggins SH Phan BL Wharram HJ Showell DG Remick, et al. 1989 Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells Biochem Biophys Res Commun 162 694 700 10.1016/0006-291X(89)92366-8 1:CAS:528:DyaL1MXltlahsL0%3D 2787988
5. MB Taubman BJ Rollins M Poon J Marmur RS Green BC Berk, et al. 1992 JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells Circ Res 70 314 325 1:CAS:528:DyaK38Xht1Gqu7g%3D 1735132
6. BS Wung JJ Cheng HJ Hsieh YJ Shyy DL Wang 1997 Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1 Circ Res 81 1 7 1:CAS:528:DyaK2sXktlaiu7s%3D 9201021
7. NA Nelken SR Coughlin D Gordon JN Wilcox 1991 Monocyte chemoattractant protein-1 in human atheromatous plaques J Clin Invest 88 1121 1127 10.1172/JCI115411 1:CAS:528:DyaK3MXmsFeitL4%3D 1843454
8. S Yla-Herttuala BA Lipton ME Rosenfeld T Sarkioja T Yoshimura EJ Leonard, et al. 1991 Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions Proc Natl Acad Sci USA 88 5252 5256 10.1073/pnas.88.12.5252 1:CAS:528:DyaK3MXksVOjur0%3D 2052604
9. M Takeya T Yoshimura EJ Leonard K Takahashi 1993 Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody Hum Pathol 24 534 539 10.1016/0046-8177(93)90166-E 1:STN:280:DyaK3s3lvFKgsw%3D%3D 7684023
10. L Gu Y Okada SK Clinton C Gerard GK Sukhova P Libby, et al. 1998 Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Mol Cell 2 275 281 10.1016/S1097-2765(00) 80139-2 1:CAS:528:DyaK1cXmtVyisrc%3D 9734366
11. J Gosling S Slaymaker L Gu S Tseng CH Zlot SG Young, et al. 1999 MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B J Clin Invest 103 773 778 10.1172/JCI5624 1:CAS:528:DyaK1MXhvFaku7w%3D 10079097
12. -/- mice reveals a role for chemokines in the initiation of atherosclerosis Nature 394 894 897 10.1038/29788 1:CAS:528:DyaK1cXlvVemsLY%3D 9732872
13. RJ Aiello PK Bourassa S Lindsey W Weng E Natoli BJ Rollins, et al. 1999 Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 19 1518 1525 1:CAS:528:DyaK1MXktVKms78%3D 10364084
14. I Martinovic N Abegunewardene M Seul M Vosseler G Horstick M Buerke, et al. 2005 Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease Circ J 69 1484 1489 10.1253/circj.69.1484 1:CAS:528:DC%2BD2MXhtlamsLjP 16308496
15. W Ni K Egashira S Kitamoto C Kataoka M Koyanagi S Inoue, et al. 2001 New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice Circulation 103 2096 2101 1:CAS:528: DC%2BD3MXjvVarsbg%3D 11319201
16. S Inoue K Egashira W Ni S Kitamoto M Usui K Otani, et al. 2002 Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice Circulation 106 2700 2706 10.1161/01.CIR.0000038140.80105.AD 1:CAS:528:DC%2BD38XosFCrsr4%3D 12438296
17. A Tedgui Z Mallat 2006 Cytokines in atherosclerosis: pathogenic and regulatory pathways Physiol Rev 86 515 581 10.1152/physrev.00024.2005 1:CAS:528:DC%2BD28Xktlylu7g%3D 16601268
18. C Buono CE Come G Stavrakis GF Maguire PW Connelly AH Lichtman 2003 Influence of interferon-γ on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse Arterioscler Thromb Vasc Biol 23 454 460 10.1161/01.ATV.0000059419.11002.6E 1:CAS:528:DC%2BD3sXhslWhsbs%3D 12615659
19. JL Barks JJ McQuillan F Iademarco 1997 TNF-α and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells J Immunol 159 4532 4587 1:CAS:528:DyaK2sXmvVynurw%3D 9379054
20. K Blease J Seybold IM Adcock PG Hellewell A Burke-Gaffney 1998 Interleukin-4 and lipopolysaccharide synergize to induce vascular cell adhesion molecule-1 expression in human lung microvascular endothelial cells Am J Respir Cell Mol Biol 18 620 630 1:CAS:528:DyaK1cXjtFaiuro%3D 9569232
21. P Davenport PG Tipping 2003 The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice Am J Pathol 163 1117 1125 1:CAS:528:DC%2BD3sXnsVCisrc%3D 12937153
22. P Galéa G Thibault M Lacord P Bardos Y Lebranchu 1993 IL-4, but not tumor necrosis factor-alpha, increases endothelial cell adhesiveness for lymphocytes by activating a cAMP-dependent pathway J Immunol 151 588 596 7687617
23. HY Hong HY Lee W Kwak J Yoo MH Na IS So, et al. 2008 Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis J Cell Moll Med 12 2003 2014 10.1111/j.1582-4934.2008.00189.x 1:CAS:528:DC%2BD1cXhsVOgu73E
24. H Huang A Lavoie-Lamoureux K Moran JP Lavoie 2007 IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol 292 L1147 L1154 10.1152/ajplung.00294.2006 1:CAS:528:DC%2BD2sXls1yhsLs%3D 17494951
25. VL King SJ Szilvassy A Daugherty 2002 Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice Arterioscler Thromb Vasc Biol 22 456 461 10.1161/hq0302.104905 1:CAS:528:DC%2BD38XitFGgsrw%3D 11884290
26. YW Lee SY Eum KC Chen B Hennig M Toborek 2004 Gene expression profile in interleukin-4-stimulated human vascular endothelial cells Mol Med 10 19 27 10.2119/2004-00024.Lee 1:CAS:528:DC%2BD2cXhtVeqs7zK 15502879
27. YW Lee AA Hirani 2006 Role of interleukin-4 in atherosclerosis Arch Pharm Res 29 1 15 10.1007/BF02977462 1:CAS:528:DC%2BD28XitVOmtr0%3D 16491837
28. YW Lee H Kühn B Hennig AS Neish M Toborek 2001 IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells J Mol Cell Cardiol 33 83 94 10.1006/jmcc.2000.1278 1:CAS:528:DC%2BD3cXptVynsr4%3D 11133225
29. YW Lee H Kühn S Kaiser B Hennig A Daughterty M Toborek 2001 Interleukin 4 induces transcription of the 15-lipoxygenase I gene in human endothelial cells J Lipid Res 42 783 791 1:CAS:528:DC%2BD3MXktFOqu7k%3D 11352986
30. B Masinovsky D Urdal WM Gallatin 1990 IL-4 acts synergistically with IL-1β to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1 J Immunol 145 2886 2895 1:CAS:528:DyaK3MXit1Wlug%3D%3D 1698865
31. WE Paul 1991 Interleukin-4: a prototypic immunoregulatory lymphokine Blood 77 1859 1870 1:CAS:528:DyaK3MXmt12ksbg%3D 2018830
32. - and systolic blood pressure in mice Circ Res 89 408 411 10.1161/hh1701.096037 1:CAS:528:DC%2BD3MXmvFSrt7k%3D 11532901
33. M Rocken M Racke EM Shevach 1996 IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease Immunol Today 17 225 231 10.1016/0167-5699(96)80556-1 1:STN:280:DyaK2s7gsV2muw%3D%3D 8991384
34. L Walch L Massade M Dufilho A Brunet F Rendu 2006 Pro-atherogenic effect of interleukin-4 in endothelial cells: modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression Atherosclerosis 187 285 291 10.1016/j.atherosclerosis.2005.09.016 1:CAS:528:DC%2BD28Xms1ags7Y%3D 16249002
35. YW Lee WH Lee PH Kim 2010 Oxidative mechanisms of IL-4-induced IL-6 expression in vascular endothelium Cytokine 49 73 79 10.1016/j.cyto.2009.08.009 1:CAS:528:DC%2BD1MXhsFyku7nF 19822443
36. YW Lee H Kühn B Hennig A Daughterty M Toborek 2000 IL-4 induces apoptosis of endothelial cells through the caspase-3-dependent pathway FEBS Lett 485 122 126 10.1016/S0014-5793(00)02208-0 1:CAS:528:DC%2BD3cXotlGjsrg%3D 11094153
37. T Sasaguri N Arima A Tanimoto S Shimajiri T Hamada Y Sasaguri 1998 A role for interleukin 4 in production of matrix metalloproteinase 1 by human aortic smooth muscle cells Atherosclerosis 138 247 253 10.1016/S0021-9150(97)00296-7 1:CAS:528:DyaK1cXksFyjtrk%3D 9690907
38. CC Chen AM Manning 1996 TGF-β1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells Cytokine 8 58 65 10.1006/cyto.1995.0008 1:CAS:528:DyaK28XhtVWqtrw%3D 8742067
39. BL Bennett R Cruz RG Lacson AM Manning 1997 Interleukin-4 suppression of tumor necrosis factor α-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-κB J Biol Chem 272 10212 10219 10.1074/jbc.272.15.10212 1:CAS:528:DyaK2sXisFOmtbo%3D 9092569
40. PS Wright JR Cooper KE Kropp SJ Busch 1999 Induction of vascular cell adhesion molecule-1 expression by IL-4 in human aortic endothelial cells is not associated with increased nuclear NF-κB levels J Cell Physiol 180 381 389 10.1002/(SICI)1097-4652(199909)180:3<381::AID-JCP9>3.0.CO;2-F 1:CAS:528:DyaK1MXks1Wnt7s%3D 10430178
41. M Toborek YW Lee S Kaiser B Hennig 2002 Measurement of inflammatory properties of fatty acids in human endothelial cells Methods Enzymol 352 198 219 10.1016/S0076-6879(02)52020-6 1:CAS:528:DC%2BD38XotFejs78%3D 12125348
42. X Deng H Li YW Tang 2003 Cytokine expression in respiratory syncytial virus-infected mice as measured by quantitative reverse-transcriptase PCR J Virol Methods 107 141 146 10.1016/S0166-0934(02)00211-2 1:CAS:528: DC%2BD38Xpslansb8%3D 12505627
43. YW Lee WH Lee 2008 Protective effects of genistein on pro-inflammatory pathways in human brain microvascular endothelial cells J Nutr Biochem 19 819 825 10.1016/j.jnutbio.2007.10.006 1:CAS:528:DC%2BD1cXhtlGls7vM 18479900
44. -δCT method Methods 25 402 408 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D 11846609
45. BJ Rollins 1997 Chemokines Blood 90 909 928 1:CAS:528:DyaK2sXkvVWiu7k%3D 9242519
46. L Gu SC Tseng BJ Rollins 1999 Monocyte chemoattractant protein-1 Chem Immunol 72 7 29 10.1159/000058723 1:CAS:528:DyaK1MXntFSntL0%3D 10550927
47. CA Bursill KM Channon DR Greaves 2004 The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics Curr Opin Lipidol 15 145 149 10.1097/00041433-200404000-00007 1:CAS:528:DC%2BD2cXjslWqsbg%3D 15017357
48. YA Sheikine GK Hansson 2006 Chemokines as potential therapeutic targets in atherosclerosis Curr Drug Targets 7 13 27 10.2174/138945006775270240 1:CAS:528:DC%2BD28XitlOktg%3D%3D 16454697
49. V Braunersreuther F Mach S Steffens 2007 The specific role of chemokines in atherosclerosis Thromb Haemost 97 714 721 1:CAS:528:DC%2BD2sXlvVygtb8%3D 17479181
50. MA Gimbrone MP Bevilacqua MI Cybulsky 1990 Endothelial-dependent mechanisms of leukocyte adhesion in inflammation and atherosclerosis Ann NY Acad Sci 598 77 85 10.1111/j.1749-6632.1990.tb42279.x 1701076
51. A Iseki F Kambe K Okumura S Niwata R Yamamoto T Hayakawa, et al. 2000 Pyrrolidine dithiocarbamate inhibits TNF-α-dependent activation of NF-κB by increasing intracellular copper level in human aortic smooth muscle cells Biochem Biophys Res Commun 276 88 92 10.1006/bbrc.2000.3452 1:CAS:528:DC%2BD3cXmslKntb4%3D 11006087
52. GL Tipoe TM Leung MW Hung ML Fung 2007 Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection Cardiovasc Hematol Disord Drug Targets 7 135 144 1:CAS:528:DC%2BD2sXkvFChtb8%3D 17584048
53. G Basta G Lazzerini S Del Turco GM Ratto AM Schmidt R De Caterina 2005 At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products Arterioscler Thromb Vasc Biol 25 1401 1407 10.1161/01.ATV.0000167522.48370.5e 1:CAS:528:DC%2BD2MXltlSis70%3D 15845907
54. B Hennig M Toborek CJ McClain JN Diana 1996 Nutritional implications in vascular endothelial cell metabolism J Am Coll Nutr 15 345 358 1:CAS:528:DyaK28XltFWjsb0%3D 8829090
55. D Sorescu D Weiss B Lassegue RE Clempus K Szocs GP Sorescu, et al. 2002 Superoxide production and expression of Nox family proteins in human atherosclerosis Circulation 105 1429 1435 10.1161/01.CIR.0000012917.74432.66 1:CAS:528:DC%2BD38XjsVyrtbw%3D 11914250
56. TJ Guzik J Sadowski B Guzik A Jopek B Kapelak P Przybylowski, et al. 2006 Coronary artery superoxide production and nox isoform expression in human coronary artery disease Arterioscler Thromb Vasc Biol 26 333 339 10.1161/01.ATV.0000196651.64776.51 1:CAS:528:DC%2BD28XksFKquw%3D%3D 16293794
57. B Hennig CK Chow 1988 Lipid peroxidation and endothelial cells injury: implication in atherosclerosis Free Radical Biol Med 4 99 106 10.1016/0891-5849(88)90070-6 1:CAS:528:DyaL1cXhsVyjs7s%3D
58. SR Thomas PK Witting GR Drummond 2008 Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities Antioxid Redox Signal 10 1713 1765 10.1089/ars.2008.2027 1:CAS:528: DC%2BD1cXpvFGru7g%3D 18707220
59. T Heitzer T Schlinzig K Krohn T Meinertz T Munzel 2001 Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease Circulation 104 2673 2678 10.1161/hc4601.099485 1:CAS:528:DC%2BD38Xht1CitQ%3D%3D 11723017
60. S Yla-Herttuala 1992 Gene expression in atherosclerotic lesions Hertz 17 270 276 1:STN:280:DyaK3s7hsVOhuw%3D%3D
61. R Ross 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 801 809 10.1038/362801a0 1:CAS:528:DyaK3sXktVGqu7c%3D 8479518
62. R Brinckmann MS Topp I Zalan D Heydeck P Ludwig H Kühn, et al. 1996 Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4 Biochem J 318 305 312 1:CAS:528:DyaK28XltlKqs7w%3D 8761486
63. K Bedard K Krause 2007 The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol Rev 87 245 313 10.1152/physrev.00044.2005 1:CAS:528:DC%2BD2sXitVagsr4%3D 17237347